Investigation of the role of adrenergic and non-nitrergic, non-adrenergic neurotransmission in the sheep isolated internal anal sphincter

Neurogastroenterology and Motility

Volumn 21, Issue 3, 2009, Pages 335-345

  Acheson, A ^a   Rayment, S ^a   Eames, T ^a   Mundey, M ^a   Nisar, P ^a   Scholefield, J ^a   Wilson, V G ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Anal sphincter; Electrical field stimulation; Neurotransmission; Noradrenaline

Indexed keywords

2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; ADENOSINE TRIPHOSPHATE; APAMIN; BRETYLIUM; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN; PRAZOSIN; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SURAMIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADRENERGIC ACTIVITY; ADRENERGIC NERVE; ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANUS SPHINCTER; ARTICLE; CONTROLLED STUDY; ELECTRIC FIELD; INTESTINE CONTRACTION; NITRERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; SHEEP;

ADENOSINE DIPHOSPHATE; ADRENERGIC ALPHA-ANTAGONISTS; ANAL CANAL; ANIMALS; ANTI-ARRHYTHMIA AGENTS; APAMIN; BRETYLIUM COMPOUNDS; ELECTRIC STIMULATION; ENZYME INHIBITORS; EPINEPHRINE; HUMANS; MUSCLE CONTRACTION; MUSCLE TONUS; NEUROTRANSMITTER AGENTS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NOREPINEPHRINE; PRAZOSIN; SHEEP; STRESS, MECHANICAL; SURAMIN; SYNAPTIC TRANSMISSION;

EID: 60649114534     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2008.01250.x     Document Type: Article

References (32)

1. G-Nitro-L-arginine reduces non-adrenergic, non-cholinergic relaxations of human gut. Gastroenterology 1992 102 : 679 83.
2. O'kelly TJ, Brading A, Mortensen NJ. In vitro response of the human anal canal longitudinal muscle layer to cholinergic and adrenergic stimulation: evidence of sphincter specialization. Br J Surg 1993 80 : 1337 41.
3. Mundey MK, Jonas M, Worthley T, Scholefield JH, Wilson VG. Pharmacological characterisation of neurogenic responses of the sheep isolated internal anal sphincter. Br J Pharmacol 2000 130 : 489 94.
4. Rae MG, Muir TC. Neuronal mediators of inhibitory junction potentials and relaxation in the guinea-pig anal sphincter. J Physiol 1996 493 : 517 27.
5. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vivo and in vitro. Br J Pharmacol 1990 101 : 746 52.
6. De Luca A, Li CG, Rand MJ. Nitrergic and purinergic mechanisms and their interaction for relaxation of the rat internal anal sphincter. J Auton Pharmacol 1999 19 : 29 37.
7. Rattan S, Chakder S. Role of nitric oxide as a mediator of internal anal sphincter relaxation. Am J Physiol 1992 262 : G107 12.
8. Chakader S, Rattan S. Evidence for VIP-induced increase in NO production in myenteric neurons of opossum internal anal sphincter. Am J Physiol 1996 270 : G492 7.
9. Watkins CC, Boehning D, Kaplin AI, Rao M, Ferris CD, Synder S. Carbon monoxide mediates vasoactive intestinal polypeptide-associated non-adrenergic/cholinergic neurotransmission. Proc Natl Acad Sci 2004 101 : 2631 5.
10. Guttierrez JG, Shah AN. Autonomic control of the internal anal sphincter in man. In : Trappen G, ed. Vth International Symposium on Gastrointestinal Motility. Leuven : Typoff Press, 1975 : 363 73.
11. Pitt J, Dawson PM, Hallan RI, Boulos PB. A double-blind radomized placebo-controlled trial of oral indoramin to treat chronic anal fissures. Colorectal Dis 2001 3 : 165 8.
12. Yamato S, Rattan S. Role of alpha adrenoceptors in opposum internal anal sphincter. J Clin Invest 1990 86 : 424 9.
13. Glavind EB, Forman A, Madsen G, Tottrup A. Effects of transmural field stimulation in isolated smooth muscle of human rectum and internal anal sphincter. Am J Physiol 1997 272 : G1075 82.
14. Nisar PJ, Gruss HJ, Bush D, Barras N, Acheson AG, Scholefield JH. Intra-anal and rectal application of L-erythromethoxamine gel increases anal resting pressure in healthy volunteers. Br J Surg 2005 92 : 1539 45.
15. Kim NN, Goldstein I, Moreland RB, Triash AM. Alpha-adrenergic receptor blockade by phentolamine increases the efficacy of vasodilators in penile corpus cavernosum. Int J Impot Res 2000 12 (Suppl. 1 S26 36.
16. Angulo J, Cuevas P, Fernandez A, Gabancho S, Saenz De Tejada I. Combination of phentolamine and L-arginine or sildenafil synergistically improves neurogenic relaxation of rabbit corpus cavernosum smooth muscle. Urology 2001 57 : 585 9.
17. Bennett M. Rebound excitation of smooth muscle of guinea-pig taeni coli after stimulation of intramural inhibitory nerves. J Physiol 1966 185 : 124 31.
18. Shieh C-C, Coughlan M, Sullivan M, Gopalakrishnan M. Potassium channels: molecular defects, diseases and therapeutic opportunities. Pharmacol Rev 2000 52 : 557 93.
19. Ward SM, Dalziel HH, Thornbury KD, Westfall DP, Sanders KM. Nonadrenergic, noncholinergic inhibition and rebound excitation in canine colon depends on nitric oxide. Am J Physiol 1992 262 : G237 43.
20. Tomita R, Tanjoh K, Fujisaki S, Fukuzawa M. The role of nitric oxide (NO) in human internal anal sphincter. J Gasteroenterol 2001 36 : 386 91.
21. Brock JA, Cunnane TC. Studies on the mode of action of bretylium and guanethidine in postganglionic sympathetic fibres. Naunyn Schmiedebergs Arch Pharmacol 1988 338 : 504 9.
22. Cobine CA, Fong M, Hamilton R, Keef KD. Species dependent differences in the actions of sympathetic nerves and noradrenaline in the internal anal sphincter. Neurogastroenterol Motil 2007 19 : 937 45.
23. Mcgrath JC, Brown CM, Wilson VG. α-adrenoceptors: a critical review. Med Res Rev 1989 9 : 408 531.
24. Mallard NJ, Hudson AL, Nutt DJ. Characterization and autoradiographical localization of non-adrenoceptor, idazoxan binding sites in the rat brain. Br J Pharmacol 1992 106 : 1019 27.
25. Bhardwaj R, Vaizey CJ, Boulos PB. Neuromyogenic properties of the internal anal sphincter: therapeutic rationale for anal fissures. Gut 2000 46 : 861 8.
26. Cook TA, Brading AF, Mortensen NJ. The pharmacology of the internal anal sphincter and new treatments of ano-rectal disorders. Aliment Pharmacol Ther 2001 15 : 887 98.
27. Jones OM, Brading AF, Mortensen NJ. Mechanism of action of botulinium toxin on the internal anal sphincter. Br J Pharmacol 2003 91 : 224 8.
28. Takeuchi T, Kishi M, Hirayama N et al. Tyrosine kinase involvement in apamin-sensitive inhibitory responses of the rat distal colon. J Physiol 1999 514 : 177 88.
29. Lenard L, Lazar Z, Benko R et al. Inhibitory effect of PACAP (6-38) on relaxations induced by PACAP, VIP and non-adrenergic, non-cholinergic nerve stimulation in the guinea-pig taenia coli. Naunyn Schmiedebergs Arch Pharmacol 2000 361 : 492 7.
30. Lefebyre RA, Smit GJ, Timmermans JP. Study of the NO and VIP as non-adrenergic, non-cholinergic neurotransmitters in the pig gastric fundus. Br J Pharmacol 1995 116 : 2017 26.
31. Burnstock G. Pathophysiology and therapeutic potential of purinoceptor signaling. Pharmacol Rev 2006 58 : 58 86.
32. Jenkinson KM, Reid JJ. The P(2)-purinoceptor antagonist suramin is a competitive antagonist at vasoactive intestinal peptide receptors in the rat gastric fundus. Br J Pharmacol 2000 130 : 1632 8.